These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12419370)

  • 21. Potent inhibition of insulin receptor dephosphorylation by a hexamer peptide containing the phosphotyrosyl mimetic F2Pmp.
    Burke TR; Kole HK; Roller PP
    Biochem Biophys Res Commun; 1994 Oct; 204(1):129-34. PubMed ID: 7524496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphotyrosyl mimetics in the development of signal transduction inhibitors.
    Burke TR; Lee K
    Acc Chem Res; 2003 Jun; 36(6):426-33. PubMed ID: 12809529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macrocyclization in the design of Grb2 SH2 domain-binding ligands exhibiting high potency in whole-cell systems.
    Wei CQ; Gao Y; Lee K; Guo R; Li B; Zhang M; Yang D; Burke TR
    J Med Chem; 2003 Jan; 46(2):244-54. PubMed ID: 12519063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-based design and synthesis of phosphinate isosteres of phosphotyrosine for incorporation in Grb2-SH2 domain inhibitors. Part 2.
    Walker CV; Caravatti G; Denholm AA; Egerton J; Faessler A; Furet P; García-Echeverría C; Gay B; Irving E; Jones K; Lambert A; Press NJ; Woods J
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2343-6. PubMed ID: 11055352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peptide probes containing a non-hydrolyzable phosphotyrosine-mimetic residue for enrichment of protein tyrosine phosphatases.
    Tsumagari K; Niinae T; Otaka A; Ishihama Y
    Proteomics; 2022 Feb; 22(4):e2100144. PubMed ID: 34714599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of macrocyclic Grb2 SH2 domain-binding peptide mimetics prepared by ring-closing metathesis of C-terminal allylglycines with an N-terminal beta-vinyl-substituted phosphotyrosyl mimetic.
    Oishi S; Karki RG; Shi ZD; Worthy KM; Bindu L; Chertov O; Esposito D; Frank P; Gillette WK; Maderia M; Hartley J; Nicklaus MC; Barchi JJ; Fisher RJ; Burke TR
    Bioorg Med Chem; 2005 Apr; 13(7):2431-8. PubMed ID: 15755645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Late Stage Phosphotyrosine Mimetic Functionalization of Peptides Employing Metallaphotoredox Catalysis.
    Chen H; Mao R; Brzozowski M; Nguyen NH; Sleebs BE
    Org Lett; 2021 Jun; 23(11):4244-4249. PubMed ID: 34029466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enantioselective synthesis of (S)-3-carboxy-4-((carboxy)difluoromethyl)phenylalanine in protected form and its incorporation into a PTP-1B-directed tripeptide.
    Kang SU; Gao Y; Wu L; Zhang ZY; Burke TR
    Chem Biodivers; 2004 Apr; 1(4):626-33. PubMed ID: 17191873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small peptides containing phosphotyrosine and adjacent alphaMe-phosphotyrosine or its mimetics as highly potent inhibitors of Grb2 SH2 domain.
    Liu WQ; Vidal M; Gresh N; Roques BP; Garbay C
    J Med Chem; 1999 Sep; 42(18):3737-41. PubMed ID: 10479306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel phosphotyrosine mimetic 4'-carboxymethyloxy-3'-phosphonophenylalanine (Cpp): exploitation in the design of nonpeptide inhibitors of pp60(Src) SH2 domain.
    Kawahata N; Yang MG; Luke GP; Shakespeare WC; Sundaramoorthi R; Wang Y; Johnson D; Merry T; Violette S; Guan W; Bartlett C; Smith J; Hatada M; Lu X; Dalgarno DC; Eyermann CJ; Bohacek RS; Sawyer TK
    Bioorg Med Chem Lett; 2001 Sep; 11(17):2319-23. PubMed ID: 11527723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CH/pi hydrogen bonds determine the selectivity of the Src homology 2 domain to tyrosine phosphotyrosyl peptides: an ab initio fragment molecular orbital study.
    Ozawa T; Okazaki K
    J Comput Chem; 2008 Dec; 29(16):2656-66. PubMed ID: 18484636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a phosphatase-stable phosphotyrosyl mimetic suitably protected for the synthesis of high-affinity Grb2 SH2 domain-binding ligands.
    Wei CQ; Li B; Guo R; Yang D; Burke TR
    Bioorg Med Chem Lett; 2002 Oct; 12(19):2781-4. PubMed ID: 12217375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal structures of the human p56lck SH2 domain in complex with two short phosphotyrosyl peptides at 1.0 A and 1.8 A resolution.
    Tong L; Warren TC; King J; Betageri R; Rose J; Jakes S
    J Mol Biol; 1996 Mar; 256(3):601-10. PubMed ID: 8604142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conformationally constrained phosphotyrosyl mimetics designed as monomeric Src homology 2 domain inhibitors.
    Burke TR; Barchi JJ; George C; Wolf G; Shoelson SE; Yan X
    J Med Chem; 1995 Apr; 38(8):1386-96. PubMed ID: 7537333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Why is phosphonodifluoromethyl phenylalanine a more potent inhibitory moiety than phosphonomethyl phenylalanine toward protein-tyrosine phosphatases?
    Chen L; Wu L; Otaka A; Smyth MS; Roller PP; Burke TR; den Hertog J; Zhang ZY
    Biochem Biophys Res Commun; 1995 Nov; 216(3):976-84. PubMed ID: 7488220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and synthesis of phosphotyrosine mimetics.
    Yan Z; Kahn M; Qabar M; Urban J; Kim HO; Blaskovich MA
    Bioorg Med Chem Lett; 2003 Jun; 13(12):2083-5. PubMed ID: 12781200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein-tyrosine phosphatase inhibition by a peptide containing the phosphotyrosyl mimetic, L-O-malonyltyrosine.
    Kole HK; Akamatsu M; Ye B; Yan X; Barford D; Roller PP; Burke TR
    Biochem Biophys Res Commun; 1995 Apr; 209(3):817-22. PubMed ID: 7537500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spectroscopic characterization of the SH2- and active site-directed peptide sequences of a bivalent Src kinase inhibitor.
    Desamero RZ; Kang J; Dol C; Chinwong J; Walters K; Sivarajah T; Profit AA
    Appl Spectrosc; 2009 Jul; 63(7):767-74. PubMed ID: 19589214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ring-closing metathesis of C-terminal allylglycine residues with an N-terminal beta-vinyl-substituted phosphotyrosyl mimetic as an approach to novel Grb2 SH2 domain-binding macrocycles.
    Oishi S; Shi ZD; Worthy KM; Bindu LK; Fisher RJ; Burke TR
    Chembiochem; 2005 Apr; 6(4):668-74. PubMed ID: 15719347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and synthesis of alpha-helical peptides and mimetics.
    Garner J; Harding MM
    Org Biomol Chem; 2007 Nov; 5(22):3577-85. PubMed ID: 17971985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.